{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:34Z","timestamp":1791918934148,"version":"4.3.4"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Osteosarcoma (OS) is the most common primary solid malignant tumour of bone, with rapid progression and a very poor prognosis. Iron is an essential nutrient that makes it an important player in cellular activities due to its inherent ability to exchange electrons, and its metabolic abnormalities are associated with a variety of diseases. The body tightly regulates iron content at the systemic and cellular levels through various mechanisms to prevent iron deficiency and overload from damaging the body. OS cells regulate various mechanisms to increase the intracellular iron concentration to accelerate proliferation, and some studies have revealed the hidden link between iron metabolism and the occurrence and development of OS. This article briefly describes the process of normal iron metabolism, and focuses on the research progress of abnormal iron metabolism in OS from the systemic and cellular levels.<\/jats:p>","DOI":"10.1007\/s12672-023-00637-y","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T15:02:50Z","timestamp":1678460570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting iron metabolism in osteosarcoma"],"prefix":"10.1007","volume":"14","author":[{"given":"Xiaowei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"issue":"Suppl 7","key":"637_CR1","doi-asserted-by":"publisher","first-page":"vii320","DOI":"10.1093\/annonc\/mdq276","volume":"21","author":"J Ritter","year":"2010","unstructured":"Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21(Suppl 7):vii320-5. https:\/\/doi.org\/10.1093\/annonc\/mdq276.","journal-title":"Ann Oncol"},{"key":"637_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12935-018-0654-4","volume":"18","author":"B Otoukesh","year":"2018","unstructured":"Otoukesh B, Boddouhi B, Moghtadaei M, Kaghazian P, Kaghazian M. Novel molecular insights and new therapeutic strategies in osteosarcoma. Cancer Cell Int. 2018;18:158. https:\/\/doi.org\/10.1186\/s12935-018-0654-4.","journal-title":"Cancer Cell Int"},{"key":"637_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jbo.2018.03.002","volume":"12","author":"M Du","year":"2018","unstructured":"Du M, Wang Y, Zhao W, Wang Z, Yuan J, Bai H. Study on the relationship between livin expression and osteosarcoma. J Bone Oncol. 2018;12:27\u201332. https:\/\/doi.org\/10.1016\/j.jbo.2018.03.002.","journal-title":"J Bone Oncol"},{"key":"637_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12885-019-5642-0","volume":"19","author":"VC Chang","year":"2019","unstructured":"Chang VC, Cotterchio M, Khoo E. Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis. BMC Cancer. 2019;19:543. https:\/\/doi.org\/10.1186\/s12885-019-5642-0.","journal-title":"BMC Cancer"},{"key":"637_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12935-021-02366-0","volume":"22","author":"Q Nie","year":"2022","unstructured":"Nie Q, Hu Y, Yu X, Li X, Fang X. Induction and application of ferroptosis in cancer therapy. Cancer Cell Int. 2022;22:12. https:\/\/doi.org\/10.1186\/s12935-021-02366-0.","journal-title":"Cancer Cell Int"},{"key":"637_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/ijc.32496","volume":"146","author":"J D\u00e4chert","year":"2020","unstructured":"D\u00e4chert J, Ehrenfeld V, Habermann K, Dolgikh N, Fulda S. Targeting ferroptosis in rhabdomyosarcoma cells. Int J Cancer. 2020;146:510\u201320. https:\/\/doi.org\/10.1002\/ijc.32496.","journal-title":"Int J Cancer"},{"key":"637_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden BT. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35:830\u201349. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.002.","journal-title":"Cancer Cell"},{"key":"637_CR8","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.bbagen.2019.06.010","volume":"1863","author":"T Nakamura","year":"2019","unstructured":"Nakamura T, Naguro I, Ichijo H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochim Biophys Acta Gen Subj. 2019;1863:1398\u2013409. https:\/\/doi.org\/10.1016\/j.bbagen.2019.06.010.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"637_CR9","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/ijc.32906","volume":"147","author":"VC Chang","year":"2020","unstructured":"Chang VC, Cotterchio M, Bondy SJ, Kotsopoulos J. Iron intake, oxidative stress-related genes and breast cancer risk. Int J Cancer. 2020;147:1354\u201373. https:\/\/doi.org\/10.1002\/ijc.32906.","journal-title":"Int J Cancer"},{"key":"637_CR10","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3892\/ijo.2019.4720","volume":"54","author":"Y Chen","year":"2019","unstructured":"Chen Y, Fan Z, Yang Y, Gu C. Iron metabolism and its contribution to cancer. Int J Oncol. 2019;54:1143\u201354. https:\/\/doi.org\/10.3892\/ijo.2019.4720.","journal-title":"Int J Oncol"},{"key":"637_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","volume":"38","author":"SV Torti","year":"2018","unstructured":"Torti SV, Manz DH, Paul BT, Blanchette-Farra N, Torti FM. Iron and cancer. Annu Rev Nutr. 2018;38:97\u2013125. https:\/\/doi.org\/10.1146\/annurev-nutr-082117-051732.","journal-title":"Annu Rev Nutr"},{"key":"637_CR12","doi-asserted-by":"publisher","first-page":"100380","DOI":"10.1016\/j.jbo.2021.100380","volume":"30","author":"J Zhao","year":"2021","unstructured":"Zhao J, Zhao Y, Ma X, Zhang B, Feng H. Targeting ferroptosis in osteosarcoma. J Bone Oncol. 2021;30:100380. https:\/\/doi.org\/10.1016\/j.jbo.2021.100380.","journal-title":"J Bone Oncol"},{"key":"637_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00109-015-1284-0","volume":"93","author":"FC Luft","year":"2015","unstructured":"Luft FC. Blood and iron. J Mol Med. 2015;93:469\u201371. https:\/\/doi.org\/10.1007\/s00109-015-1284-0.","journal-title":"J Mol Med"},{"key":"637_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/nu9060609","author":"Y Li","year":"2017","unstructured":"Li Y, Jiang H, Huang G. Protein hydrolysates as promoters of non-haem iron absorption. Nutrients. 2017. https:\/\/doi.org\/10.3390\/nu9060609.","journal-title":"Nutrients"},{"key":"637_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2018.07.020","volume":"133","author":"I Yanatori","year":"2019","unstructured":"Yanatori I, Kishi F. DMT1 and iron transport. Free Radic Biol Med. 2019;133:55\u201363. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.07.020.","journal-title":"Free Radic Biol Med"},{"key":"637_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1089\/ars.2019.7956","volume":"32","author":"G Marelli","year":"2020","unstructured":"Marelli G, Allavena P. The good and the bad side of heme-oxygenase-1 in the gut. Antioxid Redox Signal. 2020;32:1071\u20139. https:\/\/doi.org\/10.1089\/ars.2019.7956.","journal-title":"Antioxid Redox Signal"},{"key":"637_CR17","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3389\/fonc.2019.01540","volume":"9","author":"V Fiorito","year":"2019","unstructured":"Fiorito V, Chiabrando D, Petrillo S, Bertino F, Tolosano E. The multifaceted role of heme in cancer. Front Oncol. 2019;9:1540. https:\/\/doi.org\/10.3389\/fonc.2019.01540.","journal-title":"Front Oncol"},{"key":"637_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04447-7","author":"J Xu","year":"2022","unstructured":"Xu J, Zhu K, Wang Y, Chen J. The dual role and mutual dependence of heme\/HO-1\/Bach1 axis in the carcinogenic and anti-carcinogenic intersection. J Cancer Res Clin Oncol. 2022. https:\/\/doi.org\/10.1007\/s00432-022-04447-7.","journal-title":"J Cancer Res Clin Oncol"},{"key":"637_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13238-014-0119-z","volume":"6","author":"C Zhang","year":"2015","unstructured":"Zhang C, Zhang F. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell. 2015;6:88\u2013100. https:\/\/doi.org\/10.1007\/s13238-014-0119-z.","journal-title":"Protein Cell"},{"key":"637_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213464","author":"MY Ali","year":"2022","unstructured":"Ali MY, Oliva CR, Flor S, Griguer CE. Mitoferrin, cellular and mitochondrial iron homeostasis. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11213464.","journal-title":"Cells"},{"key":"637_CR21","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1039\/b717196j","volume":"25","author":"SE Bowman","year":"2008","unstructured":"Bowman SE, Bren KL. The chemistry and biochemistry of heme c: functional bases for covalent attachment. Nat Prod Rep. 2008;25:1118\u201330. https:\/\/doi.org\/10.1039\/b717196j.","journal-title":"Nat Prod Rep"},{"key":"637_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104008118","author":"GC Leung","year":"2021","unstructured":"Leung GC, Fung SS, Gallio AE, Blore R, Alibhai D, Raven EL, et al. Unravelling the mechanisms controlling heme supply and demand. Proc Natl Acad Sci USA. 2021. https:\/\/doi.org\/10.1073\/pnas.2104008118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"637_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1039\/c7mt00180k","volume":"10","author":"C Wachnowsky","year":"2018","unstructured":"Wachnowsky C, Fidai I, Cowan JA. Iron-sulfur cluster biosynthesis and trafficking\u2014impact on human disease conditions. Metallomics. 2018;10:9\u201329. https:\/\/doi.org\/10.1039\/c7mt00180k.","journal-title":"Metallomics"},{"key":"637_CR24","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.bbadis.2015.03.011","volume":"1852","author":"B Silva","year":"2015","unstructured":"Silva B, Faustino P. An overview of molecular basis of iron metabolism regulation and the associated pathologies. Biochim Biophys Acta. 2015;1852:1347\u201359. https:\/\/doi.org\/10.1016\/j.bbadis.2015.03.011.","journal-title":"Biochim Biophys Acta"},{"key":"637_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/BJ20101825","volume":"434","author":"J Wang","year":"2011","unstructured":"Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J. 2011;434:365\u201381. https:\/\/doi.org\/10.1042\/BJ20101825.","journal-title":"Biochem J"},{"key":"637_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/s1357-2725(02)00258-3","volume":"35","author":"D Trinder","year":"2003","unstructured":"Trinder D, Baker E. Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol. 2003;35:292\u20136. https:\/\/doi.org\/10.1016\/s1357-2725(02)00258-3.","journal-title":"Int J Biochem Cell Biol"},{"key":"637_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41586-020-2668-z","volume":"586","author":"CB Billesb\u00f8lle","year":"2020","unstructured":"Billesb\u00f8lle CB, Azumaya CM, Kretsch RC, Powers AS, Gonen S, Schneider S, et al. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature. 2020;586:807\u201311. https:\/\/doi.org\/10.1038\/s41586-020-2668-z.","journal-title":"Nature"},{"key":"637_CR28","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/ijc.30797","volume":"141","author":"P Jakszyn","year":"2017","unstructured":"Jakszyn P, Fonseca-Nunes A, Lujan-Barroso L, Aranda N, Tous M, Arija V, et al. Hepcidin levels and gastric cancer risk in the EPIC-EurGast study. Int J Cancer. 2017;141:945\u201351. https:\/\/doi.org\/10.1002\/ijc.30797.","journal-title":"Int J Cancer"},{"key":"637_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2141.2007.06638.x","volume":"138","author":"O Weizer-Stern","year":"2007","unstructured":"Weizer-Stern O, Adamsky K, Margalit O, Ashur-Fabian O, Givol D, Amariglio N, et al. Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53. Br J Haematol. 2007;138:253\u201362. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06638.x.","journal-title":"Br J Haematol"},{"key":"637_CR30","doi-asserted-by":"publisher","first-page":"1559S","DOI":"10.3945\/ajcn.117.155804","volume":"106","author":"GJ Anderson","year":"2017","unstructured":"Anderson GJ, Frazer DM. Current understanding of iron homeostasis. Am J Clin Nutr. 2017;106:1559S-1566S. https:\/\/doi.org\/10.3945\/ajcn.117.155804.","journal-title":"Am J Clin Nutr"},{"key":"637_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12885-016-2228-y","volume":"16","author":"O Marques","year":"2016","unstructured":"Marques O, Porto G, R\u00eama A, Faria F, Cruz Paula A, Gomez-Lazaro M, et al. Local iron homeostasis in the breast ductal carcinoma microenvironment. BMC Cancer. 2016;16:187. https:\/\/doi.org\/10.1186\/s12885-016-2228-y.","journal-title":"BMC Cancer"},{"key":"637_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.nutr.28.061807.155521","volume":"28","author":"MU Muckenthaler","year":"2008","unstructured":"Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element\/iron-regulatory protein (IRE\/IRP) regulatory network. Annu Rev Nutr. 2008;28:197\u2013213. https:\/\/doi.org\/10.1146\/annurev.nutr.28.061807.155521.","journal-title":"Annu Rev Nutr"},{"key":"637_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cmet.2007.10.006","volume":"7","author":"B Galy","year":"2008","unstructured":"Galy B, Ferring-Appel D, Kaden S, Gr\u00f6ne HJ, Hentze MW. Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab. 2008;7:79\u201385. https:\/\/doi.org\/10.1016\/j.cmet.2007.10.006.","journal-title":"Cell Metab"},{"key":"637_CR34","first-page":"3","volume":"21","author":"JL Spivak","year":"1994","unstructured":"Spivak JL. Cancer-related anemia: its causes and characteristics. Semin Oncol. 1994;21:3\u20138.","journal-title":"Semin Oncol"},{"key":"637_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3322\/canjclin.39.5.296","volume":"39","author":"D Steinberg","year":"1989","unstructured":"Steinberg D. Anemia and cancer. CA Cancer J Clin. 1989;39:296\u2013304. https:\/\/doi.org\/10.3322\/canjclin.39.5.296.","journal-title":"CA Cancer J Clin"},{"key":"637_CR36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/(sici)1097-0215(19990719)82:2<282::aid-ijc20>3.0.co;2-r","volume":"82","author":"N Rochet","year":"1999","unstructured":"Rochet N, Dubousset J, Mazeau C, Zanghellini E, Farges MF, de Novion HS, et al. Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72). Int J Cancer. 1999;82:282\u20135. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19990719)82:2%3c282::aid-ijc20%3e3.0.co;2-r.","journal-title":"Int J Cancer"},{"key":"637_CR37","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.2147\/OTT.S149905","volume":"10","author":"Z Wu","year":"2017","unstructured":"Wu Z, Yang W, Liu J, Zhang F. Interleukin-6 upregulates SOX18 expression in osteosarcoma. Onco Targets Ther. 2017;10:5329\u201336. https:\/\/doi.org\/10.2147\/OTT.S149905.","journal-title":"Onco Targets Ther"},{"key":"637_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2407-11-125","volume":"11","author":"SL Fossey","year":"2011","unstructured":"Fossey SL, Bear MD, Kisseberth WC, Pennell M, London CA. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines. BMC Cancer. 2011;11:125. https:\/\/doi.org\/10.1186\/1471-2407-11-125.","journal-title":"BMC Cancer"},{"key":"637_CR39","doi-asserted-by":"publisher","first-page":"e12974","DOI":"10.1111\/cpr.12974","volume":"54","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liao S, Bennett S, Tang H, Song D, Wood D, et al. STAT3 and its targeting inhibitors in osteosarcoma. Cell Prolif. 2021;54:e12974. https:\/\/doi.org\/10.1111\/cpr.12974.","journal-title":"Cell Prolif"},{"key":"637_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.bbrc.2019.05.123","volume":"515","author":"B Li","year":"2019","unstructured":"Li B, Gong J, Sheng S, Lu M, Guo S, Zhao X, et al. Increased hepcidin in hemorrhagic plaques correlates with iron-stimulated IL-6\/STAT3 pathway activation in macrophages. Biochem Biophys Res Commun. 2019;515:394\u2013400. https:\/\/doi.org\/10.1016\/j.bbrc.2019.05.123.","journal-title":"Biochem Biophys Res Commun"},{"key":"637_CR41","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.118.034545","volume":"139","author":"I Zlatanova","year":"2019","unstructured":"Zlatanova I, Pinto C, Bonnin P, Mathieu J, Bakker W, Vilar J, et al. Iron regulator hepcidin impairs macrophage-dependent cardiac repair after injury. Circulation. 2019;139:1530\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034545.","journal-title":"Circulation"},{"key":"637_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bcp.2011.03.030","volume":"82","author":"C Grigorakaki","year":"2011","unstructured":"Grigorakaki C, Morceau F, Chateauvieux S, Dicato M, Diederich M. Tumor necrosis factor \u03b1-mediated inhibition of erythropoiesis involves GATA-1\/GATA-2 balance impairment and PU1 over-expression. Biochem Pharmacol. 2011;82:156\u201366. https:\/\/doi.org\/10.1016\/j.bcp.2011.03.030.","journal-title":"Biochem Pharmacol"},{"key":"637_CR43","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep4.1717","volume":"5","author":"KV Kowdley","year":"2021","unstructured":"Kowdley KV, Gochanour EM, Sundaram V, Shah RA, Handa P. Hepcidin signaling in health and disease: ironing out the details. Hepatol Commun. 2021;5:723\u201335. https:\/\/doi.org\/10.1002\/hep4.1717.","journal-title":"Hepatol Commun"},{"key":"637_CR44","doi-asserted-by":"publisher","first-page":"37472","DOI":"10.1074\/jbc.M112.358911","volume":"287","author":"G Millonig","year":"2012","unstructured":"Millonig G, Ganzleben I, Peccerella T, Casanovas G, Brodziak-Jarosz L, Breitkopf-Heinlein K, et al. Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). J Biol Chem. 2012;287:37472\u201382. https:\/\/doi.org\/10.1074\/jbc.M112.358911.","journal-title":"J Biol Chem"},{"key":"637_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122591","author":"MY Hsu","year":"2020","unstructured":"Hsu MY, Mina E, Roetto A, Porporato PE. Iron: an essential element of cancer metabolism. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9122591.","journal-title":"Cells"},{"key":"637_CR46","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.hoc.2014.04.005","volume":"28","author":"E Nemeth","year":"2014","unstructured":"Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am. 2014;28:671\u201381, vi. https:\/\/doi.org\/10.1016\/j.hoc.2014.04.005.","journal-title":"Hematol Oncol Clin North Am"},{"key":"637_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4939-2095-2_10","volume":"844","author":"J Chifman","year":"2014","unstructured":"Chifman J, Laubenbacher R, Torti SV. A systems biology approach to iron metabolism. Adv Exp Med Biol. 2014;844:201\u201325. https:\/\/doi.org\/10.1007\/978-1-4939-2095-2_10.","journal-title":"Adv Exp Med Biol"},{"key":"637_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ijc.31384","volume":"143","author":"DA Quintana Pacheco","year":"2018","unstructured":"Quintana Pacheco DA, Sookthai D, Graf ME, Sch\u00fcbel R, Johnson T, Katzke VA, et al. Iron status in relation to cancer risk and mortality: findings from a population-based prospective study. Int J Cancer. 2018;143:561\u20139. https:\/\/doi.org\/10.1002\/ijc.31384.","journal-title":"Int J Cancer"},{"key":"637_CR49","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.biocel.2004.02.007","volume":"36","author":"P Aisen","year":"2004","unstructured":"Aisen P. Transferrin receptor 1. Int J Biochem Cell Biol. 2004;36:2137\u201343. https:\/\/doi.org\/10.1016\/j.biocel.2004.02.007.","journal-title":"Int J Biochem Cell Biol"},{"key":"637_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ng.3465","volume":"48","author":"HH Jabara","year":"2016","unstructured":"Jabara HH, Boyden SE, Chou J, Ramesh N, Massaad MJ, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74\u20138. https:\/\/doi.org\/10.1038\/ng.3465.","journal-title":"Nat Genet"},{"key":"637_CR51","doi-asserted-by":"publisher","first-page":"610","DOI":"10.2174\/1871530318666180605094706","volume":"18","author":"AA Hagag","year":"2018","unstructured":"Hagag AA, Badraia IM, Abdelmageed MM, Hablas NM, Hazzaa S, Nosair NA. Prognostic value of transferrin receptor-1 (CD71) expression in acute lymphoblastic leukemia. Endocr Metab Immune Disord Drug Targets. 2018;18:610\u20137. https:\/\/doi.org\/10.2174\/1871530318666180605094706.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"637_CR52","doi-asserted-by":"publisher","first-page":"101617","DOI":"10.1016\/j.redox.2020.101617","volume":"36","author":"TC Khoo","year":"2020","unstructured":"Khoo TC, Tubbesing K, Rudkouskaya A, Rajoria S, Sharikova A, Barroso M, et al. Quantitative label-free imaging of iron-bound transferrin in breast cancer cells and tumors. Redox Biol. 2020;36:101617. https:\/\/doi.org\/10.1016\/j.redox.2020.101617.","journal-title":"Redox Biol"},{"key":"637_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.11622\/smedj.2019138","volume":"62","author":"T Tang","year":"2021","unstructured":"Tang T, Xia Q, Xi M. Dihydroartemisinin and its anticancer activity against endometrial carcinoma and cervical cancer: involvement of apoptosis, autophagy and transferrin receptor. Singapore Med J. 2021;62:96\u2013103. https:\/\/doi.org\/10.11622\/smedj.2019138.","journal-title":"Singapore Med J"},{"key":"637_CR54","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13018-019-1301-z","volume":"14","author":"H Wu","year":"2019","unstructured":"Wu H, Zhang J, Dai R, Xu J, Feng H. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma. J Orthop Surg Res. 2019;14:296. https:\/\/doi.org\/10.1186\/s13018-019-1301-z.","journal-title":"J Orthop Surg Res"},{"key":"637_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/BJ20120625","volume":"449","author":"NS Kenneth","year":"2013","unstructured":"Kenneth NS, Mudie S, Naron S, Rocha S. TfR1 interacts with the IKK complex and is involved in IKK-NF-\u03baB signalling. Biochem J. 2013;449:275\u201384. https:\/\/doi.org\/10.1042\/BJ20120625.","journal-title":"Biochem J"},{"key":"637_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3727\/096504016X14562725373752","volume":"23","author":"M Liu","year":"2016","unstructured":"Liu M, Wang D, Li N. MicroRNA-20b downregulates HIF-1\u03b1 and inhibits the proliferation and invasion of osteosarcoma cells. Oncol Res. 2016;23:257\u201366. https:\/\/doi.org\/10.3727\/096504016X14562725373752.","journal-title":"Oncol Res"},{"key":"637_CR57","doi-asserted-by":"publisher","DOI":"10.1080\/01480545.2020.1774602","author":"M Gao","year":"2020","unstructured":"Gao M, Zheng A, Chen L, Dang F, Liu X, Gao J. Benzo(a)pyrene affects proliferation with reference to metabolic genes and ROS\/HIF-1\u03b1\/HO-1 signaling in A549 and MCF-7 cancer cells. Drug Chem Toxicol. 2020. https:\/\/doi.org\/10.1080\/01480545.2020.1774602.","journal-title":"Drug Chem Toxicol"},{"key":"637_CR58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/MOH.0000000000000494","volume":"26","author":"C Renassia","year":"2019","unstructured":"Renassia C, Peyssonnaux C. New insights into the links between hypoxia and iron homeostasis. Curr Opin Hematol. 2019;26:125\u201330. https:\/\/doi.org\/10.1097\/MOH.0000000000000494.","journal-title":"Curr Opin Hematol"},{"key":"637_CR59","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013;13:342\u201355. https:\/\/doi.org\/10.1038\/nrc3495.","journal-title":"Nat Rev Cancer"},{"key":"637_CR60","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s8756-3282(95)00176-x","volume":"17","author":"M Spanner","year":"1995","unstructured":"Spanner M, Weber K, Lanske B, Ihbe A, Siggelkow H, Sch\u00fctze H, et al. The iron-binding protein ferritin is expressed in cells of the osteoblastic lineage in vitro and in vivo. Bone. 1995;17:161\u20135. https:\/\/doi.org\/10.1016\/s8756-3282(95)00176-x.","journal-title":"Bone"},{"key":"637_CR61","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.26355\/eurrev_201805_14951","volume":"22","author":"GH Yu","year":"2018","unstructured":"Yu GH, Fu L, Chen J, Wei F, Shi WX. Decreased expression of ferritin light chain in osteosarcoma and its correlation with epithelial-mesenchymal transition. Eur Rev Med Pharmacol Sci. 2018;22:2580\u20137. https:\/\/doi.org\/10.26355\/eurrev_201805_14951.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"637_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082130","author":"AM Czarnecka","year":"2020","unstructured":"Czarnecka AM, Synoradzki K, Firlej W, Bartnik E, Sobczuk P, Fiedorowicz M, et al. Molecular biology of osteosarcoma. Cancers. 2020. https:\/\/doi.org\/10.3390\/cancers12082130.","journal-title":"Cancers"},{"key":"637_CR63","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/1471-2407-12-444","volume":"12","author":"GJ Yoshida","year":"2012","unstructured":"Yoshida GJ, Fuchimoto Y, Osumi T, Shimada H, Hosaka S, Morioka H, et al. Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: increased expression of a CD44 variant isoform after chemotherapy. BMC Cancer. 2012;12:444. https:\/\/doi.org\/10.1186\/1471-2407-12-444.","journal-title":"BMC Cancer"},{"key":"637_CR64","doi-asserted-by":"publisher","first-page":"100239","DOI":"10.1016\/j.jbo.2019.100239","volume":"17","author":"S Pollino","year":"2019","unstructured":"Pollino S, Palmerini E, Dozza B, Bientinesi E, Piccinni-Leopardi M, Lucarelli E, et al. CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338. J Bone Oncol. 2019;17:100239. https:\/\/doi.org\/10.1016\/j.jbo.2019.100239.","journal-title":"J Bone Oncol"},{"key":"637_CR65","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1038\/s41388-019-0876-5","volume":"38","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Feng X, Zhang J, Chen M, Huang E, Chen X. Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis. Oncogene. 2019;38:6256\u201369. https:\/\/doi.org\/10.1038\/s41388-019-0876-5.","journal-title":"Oncogene"},{"key":"637_CR66","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.2011415","author":"WA Azemin","year":"2021","unstructured":"Azemin WA, Alias N, Ali AM, Shamsir MS. Structural and functional characterisation of HepTH1\u20135 peptide as a potential hepcidin replacement. J Biomol Struct Dyn. 2021. https:\/\/doi.org\/10.1080\/07391102.2021.2011415.","journal-title":"J Biomol Struct Dyn"},{"key":"637_CR67","doi-asserted-by":"publisher","first-page":"33911","DOI":"10.1074\/jbc.M806432200","volume":"283","author":"F Zhang","year":"2008","unstructured":"Zhang F, Wang W, Tsuji Y, Torti SV, Torti FM. Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest. J Biol Chem. 2008;283:33911\u20138. https:\/\/doi.org\/10.1074\/jbc.M806432200.","journal-title":"J Biol Chem"},{"key":"637_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010095","author":"Y Wang","year":"2018","unstructured":"Wang Y, Yu L, Ding J, Chen Y. Iron Metabolism in Cancer. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms20010095.","journal-title":"Int J Mol Sci"},{"key":"637_CR69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2008.02.038","volume":"266","author":"D Galaris","year":"2008","unstructured":"Galaris D, Skiada V, Barbouti A. Redox signaling and cancer: the role of \u201clabile\u201d iron. Cancer Lett. 2008;266:21\u20139. https:\/\/doi.org\/10.1016\/j.canlet.2008.02.038.","journal-title":"Cancer Lett"},{"key":"637_CR70","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41419-019-1528-y","volume":"10","author":"Y Kuang","year":"2019","unstructured":"Kuang Y, Guo W, Ling J, Xu D, Liao Y, Zhao H, et al. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130\/STAT3 signaling pathway. Cell Death Dis. 2019;10:297. https:\/\/doi.org\/10.1038\/s41419-019-1528-y.","journal-title":"Cell Death Dis"},{"key":"637_CR71","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s12935-020-01494-3","volume":"20","author":"S Ni","year":"2020","unstructured":"Ni S, Kuang Y, Yuan Y, Yu B. Mitochondrion-mediated iron accumulation promotes carcinogenesis and Warburg effect through reactive oxygen species in osteosarcoma. Cancer Cell Int. 2020;20:399. https:\/\/doi.org\/10.1186\/s12935-020-01494-3.","journal-title":"Cancer Cell Int"},{"key":"637_CR72","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.freeradbiomed.2005.08.035","volume":"40","author":"J Wu","year":"2006","unstructured":"Wu J, Eckard J, Chen H, Costa M, Frenkel K, Huang X. Altered iron homeostasis involvement in arsenite-mediated cell transformation. Free Radic Biol Med. 2006;40:444\u201352. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.08.035.","journal-title":"Free Radic Biol Med"},{"key":"637_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1258\/096914103321610743","volume":"10","author":"JE Haddow","year":"2003","unstructured":"Haddow JE, Palomaki GE, McClain M, Craig W. Hereditary haemochromatosis and hepatocellular carcinoma in males: a strategy for estimating the potential for primary prevention. J Med Screen. 2003;10:11\u20133. https:\/\/doi.org\/10.1258\/096914103321610743.","journal-title":"J Med Screen"},{"key":"637_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1365-2249.2004.02515.x","volume":"137","author":"L Harhaji","year":"2004","unstructured":"Harhaji L, Vuckovic O, Miljkovic D, Stosic-Grujicic S, Trajkovic V. Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production. Clin Exp Immunol. 2004;137:109\u201316. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02515.x.","journal-title":"Clin Exp Immunol"},{"key":"637_CR75","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s00432-018-2740-3","volume":"144","author":"J Nie","year":"2018","unstructured":"Nie J, Lin B, Zhou M, Wu L, Zheng T. Role of ferroptosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2018;144:2329\u201337. https:\/\/doi.org\/10.1007\/s00432-018-2740-3.","journal-title":"J Cancer Res Clin Oncol"},{"key":"637_CR76","doi-asserted-by":"publisher","first-page":"111202","DOI":"10.1016\/j.biopha.2020.111202","volume":"136","author":"H Lin","year":"2021","unstructured":"Lin H, Chen X, Zhang C, Yang T, Deng Z, Song Y, et al. EF24 induces ferroptosis in osteosarcoma cells through HMOX1. Biomed Pharmacother. 2021;136:111202. https:\/\/doi.org\/10.1016\/j.biopha.2020.111202.","journal-title":"Biomed Pharmacother"},{"key":"637_CR77","doi-asserted-by":"publisher","first-page":"5021983","DOI":"10.1155\/2020\/5021983","volume":"2020","author":"H Lv","year":"2020","unstructured":"Lv H, Zhen C, Liu J, Shang P. \u03b2-Phenethyl isothiocyanate induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the MAPK signaling pathway. Oxid Med Cell Longev. 2020;2020:5021983. https:\/\/doi.org\/10.1155\/2020\/5021983.","journal-title":"Oxid Med Cell Longev"},{"key":"637_CR78","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/s41401-020-0376-8","volume":"41","author":"HH Lv","year":"2020","unstructured":"Lv HH, Zhen CX, Liu JY, Shang P. PEITC triggers multiple forms of cell death by GSH-iron-ROS regulation in K7M2 murine osteosarcoma cells. Acta Pharmacol Sin. 2020;41:1119\u201332. https:\/\/doi.org\/10.1038\/s41401-020-0376-8.","journal-title":"Acta Pharmacol Sin"},{"key":"637_CR79","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1186\/s12885-020-07167-8","volume":"20","author":"S Amano","year":"2020","unstructured":"Amano S, Kaino S, Shinoda S, Harima H, Matsumoto T, Fujisawa K, et al. Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. BMC Cancer. 2020;20:681. https:\/\/doi.org\/10.1186\/s12885-020-07167-8.","journal-title":"BMC Cancer"},{"key":"637_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137168","author":"Y Xue","year":"2021","unstructured":"Xue Y, Zhang G, Zhou S, Wang S, Lv H, Zhou L, et al. Iron chelator induces apoptosis in osteosarcoma cells by disrupting intracellular iron homeostasis and activating the MAPK pathway. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22137168.","journal-title":"Int J Mol Sci"},{"key":"637_CR81","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","volume":"307","author":"M Songbo","year":"2019","unstructured":"Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S. Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett. 2019;307:41\u20138. https:\/\/doi.org\/10.1016\/j.toxlet.2019.02.013.","journal-title":"Toxicol Lett"},{"key":"637_CR82","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41419-020-2272-z","volume":"11","author":"X Cheng","year":"2020","unstructured":"Cheng X, Fan K, Wang L, Ying X, Sanders AJ, Guo T, et al. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer. Cell Death Dis. 2020;11:92. https:\/\/doi.org\/10.1038\/s41419-020-2272-z.","journal-title":"Cell Death Dis"},{"key":"637_CR83","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbagen.2011.07.016","volume":"1820","author":"TR Daniels","year":"2012","unstructured":"Daniels TR, Bernabeu E, Rodr\u00edguez JA, Patel S, Kozman M, Chiappetta DA, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta. 2012;1820:291\u2013317. https:\/\/doi.org\/10.1016\/j.bbagen.2011.07.016.","journal-title":"Biochim Biophys Acta"},{"key":"637_CR84","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2217\/imt-2016-0050","volume":"8","author":"TR Daniels-Wells","year":"2016","unstructured":"Daniels-Wells TR, Penichet ML. Transferrin receptor 1: a target for antibody-mediated cancer therapy. Immunotherapy. 2016;8:991\u20134. https:\/\/doi.org\/10.2217\/imt-2016-0050.","journal-title":"Immunotherapy"},{"key":"637_CR85","doi-asserted-by":"publisher","first-page":"e21172","DOI":"10.1096\/fj.202001787R","volume":"35","author":"P Stocki","year":"2021","unstructured":"Stocki P, Szary J, Rasmussen C, Demydchuk M, Northall L, Logan DB, et al. Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1. FASEB J. 2021;35:e21172. https:\/\/doi.org\/10.1096\/fj.202001787R.","journal-title":"FASEB J"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-023-00637-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-023-00637-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-023-00637-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T15:35:19Z","timestamp":1678462519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-023-00637-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["637"],"URL":"https:\/\/doi.org\/10.1007\/s12672-023-00637-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"3 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}